AAAAAA
Results: 1-25/53
Authors:
Avery, RK
Ljungman, P
Citation: Rk. Avery et P. Ljungman, Prophylactic measures in the solid-organ recipient before transplantation, CLIN INF D, 33, 2001, pp. S15-S21
Authors:
Remberger, M
Aschan, J
Lonnqvist, B
Carlens, S
Gustafsson, B
Hentschke, P
Klaesson, S
Mattsson, J
Ljungman, P
Ringden, O
Citation: M. Remberger et al., An ethnic role for chronic, but not acute, graft-versus-host disease afterHLA-identical sibling stem cell transplantation, EUR J HAEMA, 66(1), 2001, pp. 50-56
Authors:
Tyring, S
Belanger, R
Bezwoda, W
Ljungman, P
Boon, R
Saltzman, RL
Citation: S. Tyring et al., A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients, CANCER INV, 19(1), 2001, pp. 13-22
Authors:
Hoglund, M
Ljungman, P
Weller, S
Citation: M. Hoglund et al., Comparable aciclovir exposures produced by oral valaciclovir and intravenous aciclovir in immunocompromised cancer patients, J ANTIMICRO, 47(6), 2001, pp. 855-861
Authors:
Sandstrom, M
Karlsson, MO
Ljungman, P
Hassan, Z
Jonsson, EN
Nilsson, C
Ringden, O
Oberg, G
Bekassy, A
Hassan, M
Citation: M. Sandstrom et al., Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients, BONE MAR TR, 28(7), 2001, pp. 657-664
Authors:
Ljungman, P
Ward, KN
Crooks, BNA
Parker, A
Martino, R
Shaw, PJ
Brinch, L
Brune, M
De La Camara, R
Dekker, A
Pauksen, K
Russell, N
Schwarer, AP
Cordonnier, C
Citation: P. Ljungman et al., Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation, BONE MAR TR, 28(5), 2001, pp. 479-484
Authors:
Hassan, Z
Ljungman, P
Ringden, O
Winiarski, J
Nilsson, C
Aschan, J
Whitley, HR
Hassan, M
Citation: Z. Hassan et al., Pharmacokinetics of liposomal busulphan in man, BONE MAR TR, 27(5), 2001, pp. 479-485
Authors:
Bjorkstrand, B
Svensson, H
Goldschmidt, H
Ljungman, P
Apperley, J
Mandelli, F
Marcus, R
Boogaerts, M
Alegre, A
Remes, K
Cornelissen, JJ
Blade, J
Lenhoff, S
Iriondo, A
Carlson, K
Volin, L
Littlewood, T
Goldstone, AH
San Miguel, J
Schattenberg, A
Gahrton, G
Citation: B. Bjorkstrand et al., Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT), BONE MAR TR, 27(5), 2001, pp. 511-515
Authors:
Salooja, N
Szydlo, RM
Socie, G
Rio, B
Chatterjee, R
Ljungman, P
Van Lint, MT
Powles, R
Jackson, G
Hinterberger-Fischer, M
Kolb, HJ
Apperley, JF
Citation: N. Salooja et al., Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey, LANCET, 358(9278), 2001, pp. 271-276
Authors:
Remberger, M
Aschan, J
Lonnqvist, B
Carlens, S
Gustafsson, B
Hentschke, P
Klaesson, S
Mattsson, J
Ljungman, P
Ringden, O
Citation: M. Remberger et al., An ethnic role for chronic, but not acute, graft-versus-host disease afterHLA-identical sibling stem cell transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1769-1770
Authors:
Rastad, AA
Andersson, J
Beermann, B
Bohlin, AB
Brandt, C
Eriksson, M
Ewald, U
Gothberg, S
Lind, A
Lindroth, M
Ljungman, P
Naver, L
Norrby, SR
Pauksen, K
Ransjo, U
Rebbel, H
Ostlund, MR
Sigurs, N
Stahle, L
Sawe, J
Sonnerborg, A
Uhnoo, I
Stopner, BA
Citation: Aa. Rastad et al., Management of infections caused by respiratory syncytial virus, SC J IN DIS, 33(5), 2001, pp. 323-328
Authors:
Ljungman, P
Citation: P. Ljungman, Prophylaxis against herpesvirus infections in transplant recipients, DRUGS, 61(2), 2001, pp. 187-196
Authors:
Gahrton, G
Svensson, H
Cavo, M
Apperley, J
Bacigalupo, A
Bjorkstrand, B
Blade, J
Cornelissen, J
de Laurenzi, A
Facon, T
Ljungman, P
Michallet, M
Niederwieser, D
Powles, R
Reiffers, J
Russell, NH
Samson, D
Schaefer, UW
Schattenberg, A
Tura, S
Verdonck, LF
Vernant, JP
Willemze, R
Volin, L
Citation: G. Gahrton et al., Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres, BR J HAEM, 113(1), 2001, pp. 209-216
Authors:
Ljungman, P
Cordonnier, C
Citation: P. Ljungman et C. Cordonnier, Response: Cidofovir against cytomegalovirus after allogeneic stem cell transplantation, BLOOD, 98(5), 2001, pp. 1628-1628
Authors:
Ljungman, P
Deliliers, GL
Platzbecker, U
Matthes-Martin, S
Bacigalupo, A
Einsele, H
Ullmann, J
Musso, M
Trenschel, R
Ribaud, P
Bornhauser, M
Cesaro, S
Crooks, B
Dekker, A
Gratecos, N
Klingebiel, T
Tagliaferri, E
Ullmann, AJ
Wacker, P
Cordonnier, C
Citation: P. Ljungman et al., Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients, BLOOD, 97(2), 2001, pp. 388-392
Authors:
Pauksen, K
Linde, A
Hammarstrom, V
Sjolin, J
Carneskog, J
Jonsson, G
Oberga, G
Engelmann, H
Ljungman, P
Citation: K. Pauksen et al., Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients, CLIN INF D, 30(2), 2000, pp. 342-348
Authors:
Mattsson, J
Uzunel, M
Remberger, M
Ljungman, P
Kimby, E
Ringden, O
Zetterquist, H
Citation: J. Mattsson et al., Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease, LEUKEMIA, 14(2), 2000, pp. 247-254
Authors:
Lehmann, S
Isberg, B
Ljungman, P
Paul, C
Citation: S. Lehmann et al., Cardiac systolic function before and after hematopoietic stem cell transplantation, BONE MAR TR, 26(2), 2000, pp. 187-192
Authors:
Hassan, M
Ljungman, P
Ringden, O
Hassan, Z
Oberg, G
Nilsson, C
Bekassy, A
Bielenstein, M
Abdel-Rehim, M
Georen, S
Astner, L
Citation: M. Hassan et al., The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy andtherapy-related toxicity, BONE MAR TR, 25(9), 2000, pp. 915-924
Authors:
Hassan, M
Svensson, JO
Nilsson, C
Hentschke, P
AL-Shurbaji, A
Aschan, J
Ljungman, P
Ringden, O
Citation: M. Hassan et al., Ketobemidone may alter busulfan pharmacokinetics during high-dose therapy, THER DRUG M, 22(4), 2000, pp. 383-385
Authors:
Enbom, M
Sheldon, J
Lennette, E
Schulz, T
Ablashi, DV
Neipel, F
Biberfeld, P
Carlberg, H
Ljungman, P
Nilsson, A
Soderstrom, T
Wadstrom, J
Linde, A
Citation: M. Enbom et al., Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: Variable frequencies found in amulticenter serological study, J MED VIROL, 62(4), 2000, pp. 498-504
Authors:
Bergh, J
Wiklund, T
Erikstein, B
Lidbrink, E
Lindman, H
Malmstrom, P
Kellokumpu-Lehtinen, P
Bengtsson, NO
Soderlund, G
Anker, G
Wist, E
Ottosson, S
Salminen, E
Ljungman, P
Holte, H
Nilsson, J
Blomqvist, C
Wilking, N
Citation: J. Bergh et al., Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial, LANCET, 356(9239), 2000, pp. 1384-1391
Authors:
Halfvarsson, J
Heijne, N
Ljungman, P
Ham, MN
Holmgren, G
Tomson, G
Citation: J. Halfvarsson et al., Knowing when but not how! - Mothers' perceptions and use of antibiotics ina rural area of Viet Nam, TROP DOCT, 30(1), 2000, pp. 6-10
Authors:
Hammarstrom, V
Pauksen, K
Svensson, H
Lonnqvist, B
Simonsson, B
Ringden, O
Ljungman, P
Citation: V. Hammarstrom et al., Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients, TRANSPLANT, 69(8), 2000, pp. 1582-1586
Authors:
Yun, ZB
Lewensohn-Fuchs, I
Ljungman, P
Vahlne, A
Citation: Zb. Yun et al., Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction assays, TRANSPLANT, 69(8), 2000, pp. 1733-1736